Tech Company Financing Transactions

EarliTec Diagnostics Funding Round

On 4/2/2024, EarliTec Diagnostics announced $21.5 million in Series B funding from Nexus NeuroTech Ventures, Venture Investors and private investors.

Transaction Overview

Announced On
4/2/2024
Transaction Type
Venture Equity
Amount
$21,500,000
Round
Series B
Investors

Nexus NeuroTech Ventures (Lead Investor)

Venture Investors (Lead Investor)

Proceeds Purpose
The company intends to use the funds to expand commercialization efforts and advance clinical research for the EarliPoint� Evaluation, which aids clinicians in the diagnosis and assessment of autism in children aged 16-to-30 months.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
755 Commerce Drive 700
Decatur, GA 30030
USA
Phone
Undisclosed
Email Address
Overview
Making earlier identification and treatment for autism and related vulnerabilities accessible to children everywhere. Using clinically validated measures, we are creating novel technologies that enable parents and providers to know where an individual child is on the spectrum and to tailor treatment for the greatest personal gains.
Profile
EarliTec Diagnostics LinkedIn Company Profile
Social Media
EarliTec Diagnostics Company Twitter Account
Company News
EarliTec Diagnostics News
Facebook
EarliTec Diagnostics on Facebook
YouTube
EarliTec Diagnostics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Tom Ressemann
  Tom Ressemann LinkedIn Profile  Tom Ressemann Twitter Account  Tom Ressemann News  Tom Ressemann on Facebook
Chief Financial Officer
Leota Pearson
  Leota Pearson LinkedIn Profile  Leota Pearson Twitter Account  Leota Pearson News  Leota Pearson on Facebook
Chief Scientific Officer
Warren Jones
  Warren Jones LinkedIn Profile  Warren Jones Twitter Account  Warren Jones News  Warren Jones on Facebook
Chief Technical Officer
Sreeni Narayanan
  Sreeni Narayanan LinkedIn Profile  Sreeni Narayanan Twitter Account  Sreeni Narayanan News  Sreeni Narayanan on Facebook
VP - Marketing
Michael Fox
  Michael Fox LinkedIn Profile  Michael Fox Twitter Account  Michael Fox News  Michael Fox on Facebook
VP - Operations
Ryan Bormann
  Ryan Bormann LinkedIn Profile  Ryan Bormann Twitter Account  Ryan Bormann News  Ryan Bormann on Facebook
VP - Regulatory Affairs
John Reviere
  John Reviere LinkedIn Profile  John Reviere Twitter Account  John Reviere News  John Reviere on Facebook
VP - Regulatory Affairs
Sew-Wah Tay
  Sew-Wah Tay LinkedIn Profile  Sew-Wah Tay Twitter Account  Sew-Wah Tay News  Sew-Wah Tay on Facebook
VP - Sales
Jonathan Lehmann
  Jonathan Lehmann LinkedIn Profile  Jonathan Lehmann Twitter Account  Jonathan Lehmann News  Jonathan Lehmann on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/2/2024: Coadjute venture capital transaction
Next: 4/2/2024: Agora venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary